| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Epson LabelWorks PX, the US-based sales office for Seiko Epson Corporation, announced today that it will demonstrate its new industrial printer solutions designed specifically to address the need...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
CTI BioPharma Corp. (Nasdaq: CTIC) today announced four poster presentations and one oral presentation supporting the Company's pacritinib development program at the 61st American Society of...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that abstracts for both fimepinostat and...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Kleo Pharmaceuticals, Inc., an immuno-oncology company developing next-generation, fully synthetic bispecific compounds designed to emulate or enhance the activity of biologics, announced today...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Topia, the leading provider of Global Mobility Management (GMM) software, today announced the results of a "feet on the street" survey conducted at two recent high-profile HR events. Topia polled...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Mattel (NASDAQ: MAT) announced today the winner of the 2019 Hot Wheels Legends Tour. The Nash custom car, built by best friends Greg Salzillo and Dave Ford, will be joining the Hot Wheels...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will share new and updated data for two investigational medicines for blood cancers and a third for a rare blood disease at...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced that new findings from its pivotal Phase 3 SIERRA trial for Iomab-B (Iodine-131 apamistamab) that support its...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
AllianceRx Walgreens Prime and Duquesne University School of Pharmacy recently announced results from research analyzing data from cystic fibrosis (CF) patients prescribed cystic fibrosis...
